Novo Nordisk has multiple weight-loss drugs in various stages of development and approval, according to its R&D pipeline. These include, among others, monlunabant (phase 2); oral and subcutaneous ...
If you feel nauseous after taking multivitamins, you're not alone. We asked Anastasiya Shor, PharmD, an assistant professor of pharmacy practice at the Touro College of Pharmacy in New York City, why ...
Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...
The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...
Experts weigh in on whether these stickers live up to the hype.
Is it safe to take a multivitamin daily for years? Here's what happens with long-term use, including potential benefits, risks, and how to choose the right one.
News-Medical.Net on MSN
Most weight lost on GLP-1 drugs returns within a year after stopping
By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...
Morning Overview on MSN
How the ‘holy grail’ weight loss pill finally happened and what’s next
The FDA’s approval of Wegovy on June 4, 2021, ended a seven-year drought in new obesity treatments and set off a chain reaction that has reshaped how doctors, patients, and insurers think about excess ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results